Fidelity International’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Fidelity International’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-162,000	Closed	-$10.1M	–	905
2023 Q4	$10.1M	Buy	+162,000	New	+$4.03M	0.01%	502

Fidelity International's RYZB Position: Q1 2024 in Review

Fidelity International sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 162,000 shares — an estimated $10.1M sold.

Fidelity International first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $10.1M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Fidelity International reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Fidelity International sold 162,000 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $10.1M.
Fidelity International first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Fidelity International's RayzeBio, Inc. Common Stock position peaked at $10.1M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Fidelity International's 13F filing for Q1 2024, filed 13 May 2024.